Advertisement
Advertisement
U.S. markets open in 6 hours 24 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
27.64-1.20 (-4.16%)
At close: 04:00PM EST
27.53 -0.11 (-0.40%)
After hours: 04:18PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close28.84
Open29.34
Bid0.00 x 800
Ask0.00 x 2200
Day's Range27.15 - 28.93
52 Week Range15.37 - 57.20
Volume603,853
Avg. Volume506,178
Market Cap1.29B
Beta (5Y Monthly)2.72
PE Ratio (TTM)N/A
EPS (TTM)-1.76
Earnings DateMar 28, 2022 - Apr 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est65.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CLDX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Celldex Therapeutics, Inc.
    The Argus Min Vol Model PortfolioThe onset of the coronavirus in 2020 knocked stocks into a bear market. Though equities recovered, the U.S. economy is about to slow down and COVID-19 cases are rising again as virus variants spread. Volatility, which has dropped from the highs of 2020, still has not returned to pre-COVID levels. Daily prices can swing wildly, as they did three times in 2021 when stocks dropped 4%-5% in a matter of a few days. Is it time for investors to cash in their chips? We note that investors exit the stock market at their own peril, as long-term returns from equities consistently have outpaced long-term returns from other asset classes, such as fixed income and cash. As well, those returns are from eras when the 10-year Treasury bond yield was not sub-2.0%. So what's a potential equity strategy for investors amid all the uncertainty? Argus believes that Min Vol is an all-weather strategy that is timely in any investing climate. Academic literature and, more to the point, returns history indicate that Min Vol can deliver market-matching returns on an absolute basis and superior returns on a risk-adjusted basis over various time periods.
    Rating
    Fair Value
    Economic Moat
    19 hours agoArgus Research
View more
Advertisement
Advertisement